National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL)

 

Rapid Review

Commenced Completed Outcome
03/01/2017 08/02/2017 Full HTA not recommended until further evidence available